Altered nitric oxide bioavailability contributes to diesel exhaust inhalation-induced cardiovascular dysfunction in man

J Am Heart Assoc. 2013 Feb 19;2(1):e004309. doi: 10.1161/JAHA.112.004309.

Abstract

Background: Diesel exhaust inhalation causes cardiovascular dysfunction including impaired vascular reactivity, increased blood pressure, and arterial stiffness. We investigated the role of nitric oxide (NO) bioavailability in mediating these effects.

Methods and results: In 2 randomized double-blind crossover studies, healthy nonsmokers were exposed to diesel exhaust or filtered air. Study 1: Bilateral forearm blood flow was measured during intrabrachial infusions of acetylcholine (ACh; 5 to 20 μg/min) and sodium nitroprusside (SNP; 2 to 8 μg/min) in the presence of the NO clamp (NO synthase inhibitor N(G)-monomethyl-l-arginine (l-NMMA) 8 μg/min coinfused with the NO donor SNP at 90 to 540 ng/min to restore basal blood flow). Study 2: Blood pressure, arterial stiffness, and cardiac output were measured during systemic NO synthase inhibition with intravenous l-NMMA (3 mg/kg). Following diesel exhaust inhalation, plasma nitrite concentrations were increased (68±48 versus 41±32 nmol/L; P=0.006) despite similar l-NMMA-induced reductions in basal blood flow (-20.6±14.7% versus -21.1±14.6%; P=0.559) compared to air. In the presence of the NO clamp, ACh and SNP caused dose-dependent vasodilatation that was not affected by diesel exhaust inhalation (P>0.05 for both). Following exposure to diesel exhaust, l-NMMA caused a greater increase in blood pressure (P=0.048) and central arterial stiffness (P=0.007), but reductions in cardiac output and increases in systemic vascular resistance (P>0.05 for both) were similar to those seen with filtered air.

Conclusions: Diesel exhaust inhalation disturbs normal vascular homeostasis with enhanced NO generation unable to compensate for excess consumption. We suggest the adverse cardiovascular effects of air pollution are, in part, mediated through reduced NO bioavailability.

Clinical trial registration: URL: http://www.ClinicalTrials.gov. Unique identifiers: NCT00845767 and NCT01060930.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Air Pollutants / adverse effects*
  • Arginine / blood
  • Biological Availability
  • Blood Pressure / drug effects
  • Cardiac Output / drug effects
  • Cardiovascular Diseases / chemically induced*
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / physiopathology
  • Cross-Over Studies
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Enzyme Inhibitors / administration & dosage
  • Female
  • Forearm / blood supply*
  • Hemodynamics / drug effects*
  • Humans
  • Inhalation Exposure / adverse effects*
  • Male
  • Nitric Oxide / metabolism*
  • Nitric Oxide Donors / administration & dosage
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / metabolism
  • Nitrites / blood
  • Time Factors
  • Vascular Resistance / drug effects
  • Vascular Stiffness
  • Vasoconstriction / drug effects
  • Vasodilation / drug effects
  • Vasodilator Agents / administration & dosage
  • Vehicle Emissions / toxicity*
  • Young Adult

Substances

  • Air Pollutants
  • Enzyme Inhibitors
  • Nitric Oxide Donors
  • Nitrites
  • Vasodilator Agents
  • Vehicle Emissions
  • Nitric Oxide
  • Arginine
  • Nitric Oxide Synthase

Associated data

  • ClinicalTrials.gov/NCT00845767
  • ClinicalTrials.gov/NCT01060930